youtube_live
Q4 2026 earnings • released • EPS beat +2.42% • Revenue miss -1.05%
See resultschevron_right
SMG:NYSE
Scotts Miracle-Gro Co
$66.10
arrow_downward
-1.63%(-1.10) 1D
Nov 5, 10:52:24 AM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SMG...
Open
$67.85
High
$67.85
Low
$65.64
Mkt. cap
3.85B
Avg. vol.
1.22M
Volume
296.95K
Dividend
3.99%
Quarterly dividend
$0.66
Ex-dividend date
Aug 21, 2026
P/E ratio
58.83
52-wk high
$75.34
52-wk low
$47.90
EPS
$1.12
Beta
1.87
Shares outstanding
58.22M
No. of employees
5K
Open
$67.85
High
$67.85
Low
$65.64
Mkt. cap
3.85B
Avg. vol.
1.22M
Volume
296.95K
Dividend
3.99%
Quarterly dividend
$0.66
Ex-dividend date
Aug 21, 2026
P/E ratio
58.83
52-wk high
$75.34
52-wk low
$47.90
EPS
$1.12
Beta
1.87
Shares outstanding
58.22M
No. of employees
5K
News stories
From web sources and news partners
The Business Journals
·
5 hours ago
A remade Scotts Miracle-Gro widened profit on flat sales
scanx.trade
·
21 hours ago
Scotts Miracle-Gro Q4FY26 Results: Adjusted loss narrows to $2.16 per share
Benzinga
·
1 day ago
Scotts Miracle-Gro Stock Jumps After Q4 Earnings
GuruFocus
·
1 day ago
Scotts Miracle-Gro (SMG) Shares Rise Premarket on Strong Fiscal 2027 Outlook
Profile
The Scotts Miracle-Gro Company is an American multinational corporation headquartered in Marysville, Ohio, where O.M. Scott began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products, as well as soilless indoor gardening equipment. In the U.S., the company manufactures Scotts, Miracle-Gro and Ortho brands. It also markets and distributes the herbicide Roundup in the U.S. and several international markets including China. Wikipedia
About Scotts Miracle-Gro Co
CEOJames Hagedorn
Employees5.2K
Founded1868
HeadquartersMarysville, Ohio, United States
SectorFertilizer
Industry-
Websitescottsmiraclegro.com
Analyst ratings
Based on 6 analysts giving stock ratings to SMG in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SMG in the last 3 months.
Highest
Current $66.10
$77.00 (+16.50%)
Average
$70.30 (+6.36%)
Lowest
$56.49 (-14.53%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Peter Grom UBS | Buy | Reiterated | $77.00 | +16.5% | 11/05/2026 |
Jeffrey Zekauskas J.P. Morgan | Hold | Maintained | $67.00 | +1.4% | 11/05/2026 |
Michael Ruch Wells Fargo | Buy | Reiterated | $76.00 | +15% | 11/05/2026 |
Christopher Carey Wells Fargo | Buy | Reiterated | $76.00 | +15% | 11/04/2026 |
Jon Andersen William Blair | Buy | Reiterated | - | - | 10/02/2026 |
W. Andrew Carter Stifel Nicolaus | Buy | Reiterated | $75.00 | +13.5% | 09/29/2026 |
Unknown Analyst Morgan Stanley | Buy | Maintained | CHFÂ 46.00 | -30.4% | 09/07/2026 |
Jonathan Matuszewski Jefferies | Buy | Reiterated | $79.00 | +19.5% | 06/24/2026 |
Unknown Analyst Goldman Sachs | Hold | Maintained | CHFÂ 32.00 | -51.6% | 06/04/2026 |
Last report
Nov 4, 2026
Fiscal period
Q4 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
-$2.16 / -$2.21
+2.42%beat
arrow_upward
Revenue / Est. (USD)
302.90M / 306.11M
-1.05%miss
arrow_downward
Fiscal Q4 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 387.30M | 354.40M | 1.46B | 1.17B |
Cost of goods sold | 359.60M | 264.40M | 849.00M | 805.00M |
Cost of revenue | 359.60M | 264.40M | 849.00M | 805.00M |
Research and development expenses | - | 9.80M | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 136.90M | 95.50M | 199.20M | 145.60M |
Operating expense | 142.00M | 108.70M | 206.50M | 169.90M |
Total operating expenses | 501.60M | 373.10M | 1.06B | 974.90M |
Operating income | -114.30M | -18.70M | 404.00M | 197.20M |
Other non operating income | -1.40M | -1.20M | -1.10M | -15.60M |
EBT including unusual items | -190.60M | -63.30M | 364.90M | 155.20M |
EBT excluding unusual items | -152.60M | -60.20M | 367.10M | 182.80M |
Income tax expense | -38.70M | -15.50M | 101.60M | 51.60M |
Effective tax rate | 20.30% | 24.49% | 27.84% | 33.25% |
Other operating expenses | 5.10M | 2.70M | 7.30M | 24.30M |
Net income | -151.90M | -125.00M | 238.60M | 112.20M |
Net profit margin | -39.22% | -35.27% | 16.35% | 9.57% |
Earnings per share | -1.96 | -0.77 | 4.53 | 2.82 |
Interest and investment income | - | - | - | - |
Interest expense | -26.80M | -27.20M | -31.30M | -28.00M |
Net interest expenses | -26.80M | -27.20M | -31.30M | -28.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -95.80M | -300.00K | 420.10M | 213.90M |
Gain or loss from assets sale | 17.70M | - | 134.40M | -32.60M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events